The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant interest within the British Isles, prompting a notable shift in medication trends. Access these medications remains a complex landscape, with National Health Service coverage currently limited and specialist practices offering prescriptions at a premium . Wo